Related references
Note: Only part of the references are listed.Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer
Yoshitaka Isobe et al.
EBIOMEDICINE (2020)
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future
Fabio Nicolini et al.
FRONTIERS IN ONCOLOGY (2020)
Therapeutic efficacy evaluation of radioimmunotherapy with 90Y-labeled anti-podoplanin antibody NZ-12 for mesothelioma
Hitomi Sudo et al.
CANCER SCIENCE (2019)
Podoplanin in Inflammation and Cancer
Miguel Quintanilla et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Near-Infrared Photoimmunotherapy of Cancer
Hisataka Kobayashi et al.
ACCOUNTS OF CHEMICAL RESEARCH (2019)
Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT)
Morihito Okada et al.
CLINICAL CANCER RESEARCH (2019)
Current treatment strategies in malignant pleural mesothelioma with a treatment algorithm
Mutlay Sayan et al.
ADVANCES IN RESPIRATORY MEDICINE (2019)
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline
Hedy L. Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Antibody drug conjugates in thoracic malignancies
Jose M. Pacheco et al.
LUNG CANCER (2018)
Management and Survival of Pleural Mesothelioma: A Record Linkage Study
Greta Carioli et al.
RESPIRATION (2018)
Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy
Kazuhide Sato et al.
ACS CENTRAL SCIENCE (2018)
Checkpoint Blockade in Lung Cancer and Mesothelioma
Lysanne A. Lievense et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody-Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer
Kimihiro Ito et al.
BIOCONJUGATE CHEMISTRY (2017)
PD-1 and PD-L1 antibodies in cancer: current status and future directions
Arjun Vasant Balar et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Role of Fluorophore Charge on the In Vivo Optical Imaging Properties of Near-Infrared Cyanine Dye/Monoclonal Antibody Conjugates
Kazuhide Sato et al.
BIOCONJUGATE CHEMISTRY (2016)
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
Gerard Zalcman et al.
LANCET (2016)
Effect of charge localization on the in vivo optical imaging properties of near-infrared cyanine dye/monoclonal antibody conjugates
Kazuhide Sato et al.
MOLECULAR BIOSYSTEMS (2016)
Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy
Kazuhide Sato et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Near infrared photoimmunotherapy with an anti-mesothelin antibody
Tadanobu Nagaya et al.
ONCOTARGET (2016)
Selective Cell Elimination from Mixed 3D Culture Using a Near Infrared Photoimmunotherapy Technique
Kazuhide Sato et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Anna C. Bibby et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Near infrared photoimmunotherapy for lung metastases
Kazuhide Sato et al.
CANCER LETTERS (2015)
Impact of C4'-O-Alkyl Linker on in Vivo Pharmacokinetics of Near-Infrared Cyanine/Monoclonal Antibody Conjugates
Kazuhide Sato et al.
MOLECULAR PHARMACEUTICS (2015)
Near infrared photoimmunotherapy prevents lung cancer metastases in a murine model
Kazuhide Sato et al.
ONCOTARGET (2015)
Near Infrared Photoimmunotherapy in the Treatment of Pleural Disseminated NSCLC: Preclinical Experience
Kazuhide Sato et al.
THERANOSTICS (2015)
Armed antibodies for cancer treatment: a promising tool in a changing era
Riccardo Danielli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Near Infrared Photoimmunotherapy in the Treatment of Disseminated Peritoneal Ovarian Cancer
Kazuhide Sato et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Selective cell elimination in vitro and in vivo from tissues and tumors using antibodies conjugated with a near infrared phthalocyanine
Kazuhide Sato et al.
RSC ADVANCES (2015)
Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor
Kazuhide Sato et al.
MOLECULAR ONCOLOGY (2014)
Photoimmunotherapy of Gastric Cancer Peritoneal Carcinomatosis in a Mouse Model
Kazuhide Sato et al.
PLOS ONE (2014)
A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
Yukinari Kato et al.
SCIENTIFIC REPORTS (2014)
Occupational and Environmental Exposures and Cancers in Developing Countries
Dana Hashim et al.
ANNALS OF GLOBAL HEALTH (2014)
The Global Spread of Asbestos
Arthur L. Frank et al.
ANNALS OF GLOBAL HEALTH (2014)
Significance of podoplanin expression in cancer-associated fibroblasts: A comprehensive review
Bartosz Pula et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin Antibody
Shinji Abe et al.
JOURNAL OF IMMUNOLOGY (2013)
Numb controls E-cadherin endocytosis through p120 catenin with aPKC
Kazuhide Sato et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules
Makoto Mitsunaga et al.
NATURE MEDICINE (2011)
Increasing incidence of malignant mesothelioma after exposure to asbestos during home maintenance and renovation
Nola J. Olsen et al.
MEDICAL JOURNAL OF AUSTRALIA (2011)
Malignant mesothelioma
R. M. Rudd
BRITISH MEDICAL BULLETIN (2010)
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells
Koji Kawaguchi et al.
CARCINOGENESIS (2009)
Podoplanin is a better lmmunohistochemical marker for sarcomatoid mesotheliorna than calretinin
Diana M. Padgett et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2
Yukinari Kato et al.
CANCER SCIENCE (2008)
Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain
Yukinari Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Establishment and characterization of four malignant pleural mesothelioma cell lines from Japanese patients
N Usami et al.
CANCER SCIENCE (2006)
D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma
NG Ordóñez
HUMAN PATHOLOGY (2005)
Share Paper
